Estimativas de analistas de Wall Street para Edwards Lifesciences Corporation (EW): preço alvo de consenso, recomendações de compra/manter/venda e previsões de receita, LPA e EBITDA para os próximos exercícios.
Surpresas de Resultados Recentes
| Data | LPA Real | LPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-29 | $0.73 | ||
| 2026-07-23 | $0.78 | $0.74 | +5.0% |
| 2026-04-23 | $0.78 | $0.73 | +7.0% |
| 2026-02-10 | $0.58 | $0.62 | -6.1% |
| 2025-10-30 | $0.67 | $0.60 | +12.4% |
| 2025-07-24 | $0.67 | $0.62 | +7.4% |
| 2025-04-23 | $0.64 | $0.60 | +7.4% |
| 2025-02-11 | $0.59 | $0.55 | +7.1% |
Índices de avaliação
| Índice P/L | 49.28 |
| Preço / Valor contábil | 4.65 |
| EV / EBITDA | 31.96 |
| Dividend Yield | 0.00% |
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $2.96B | $3.44B | $3.72B | $4.35B | $4.39B | $5.23B | $5.38B | $5.01B | $5.44B | $6.07B |
| Custo da Receita | $805.8M | $882.9M | $922.1M | $1.16B | $1.10B | $1.23B | $1.17B | $1.04B | $1.12B | $1.33B |
| Lucro Bruto | $2.16B | $2.55B | $2.80B | $3.19B | $3.29B | $4.01B | $4.22B | $3.97B | $4.32B | $4.74B |
| P&D | $442.2M | $552.6M | $622.2M | $752.7M | $760.7M | $903.1M | $945.2M | $962.9M | $1.05B | $1.08B |
| Despesas Gerais e Administrativas | $900.2M | $989.7M | $1.09B | $1.24B | $1.23B | $1.49B | $1.57B | $1.58B | $1.79B | $2.09B |
| Despesas Operacionais | $1.34B | $1.54B | $1.71B | $1.99B | $1.99B | $2.40B | $2.51B | $2.55B | $2.94B | $3.10B |
| Lucro Operacional | $815.5M | $1.01B | $1.09B | $1.20B | $1.30B | $1.61B | $1.70B | $1.43B | $1.38B | $1.64B |
| EBITDA | $827.1M | $1.14B | $872.2M | $1.31B | $1.07B | $1.89B | $1.96B | $1.53B | $1.72B | $1.43B |
| Despesas com Juros | $18.0M | $23.2M | $33.4M | $27.3M | $22.2M | $24.8M | $26.2M | $17.6M | $19.8M | 0 |
| Lucro Antes de Impostos | $737.9M | $1.03B | $761.4M | $1.17B | $916.7M | $1.70B | $1.77B | $1.37B | $1.55B | $1.27B |
| Imposto | $168.4M | $451.3M | $39.2M | $119.6M | $93.3M | $198.9M | $245.5M | $152.4M | $152.1M | $216.9M |
| Lucro Líquido | $569.5M | $622.1M | $722.2M | $1.05B | $823.4M | $1.50B | $1.52B | $1.40B | $4.17B | $1.07B |
| LPA | $0.89 | $0.98 | $1.15 | $1.68 | $1.32 | $2.41 | $2.46 | $2.31 | $6.98 | $1.84 |
| LPA Diluído | $0.87 | $0.96 | $1.13 | $1.64 | $1.30 | $2.38 | $2.44 | $2.30 | $6.97 | $1.83 |
| Ações em Circulação (Diluídas) | $653.4M | $647.7M | $640.8M | $636.6M | $631.9M | $631.2M | $624.2M | $609.4M | $599.3M | $585.8M |
Preço
| Preço | $89.28 |
| Capitalização | $51.4B |
| Bolsa | NYSE |
| País | US |
Empresas relacionadas: A · ALC · ARGX · BDX · BRKR · CAH · DXCM
Explorar setor: Healthcare · Medical - Devices
Mais seções de EW: Resumo · Financeiros · Avaliação · Estatísticas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações